OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR)

Historical Holders from Q3 2024 to Q2 2025

Symbol
OKUR on Nasdaq
CUSIP
68277Q105
Type / Class
Equity / Class A Common Stock, par value $0.0001 per share
Shares outstanding
12.9M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
10.8M
Holdings value
$25.8M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
48
Number of buys
22
Number of sells
-19
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACORN BIOVENTURES, L.P. 22.1% $7.1M 2.84M Anders Hove May 15, 2025
Shay Capital LLC 6.3% $2.06M 810K Shay Capital LLC May 15, 2025
VANGUARD GROUP INC 5.58% $2.08M 707K The Vanguard Group Dec 31, 2024
CANTOR FITZGERALD & CO. 5.2% $1.69M 670K Cantor Fitzgerald Securities Jun 30, 2025
HIGHBRIDGE CAPITAL MANAGEMENT LLC 5.2% +66.7% $1.68M $668K 664K +66% Highbridge Capital Management, LLC Jun 30, 2025
Deep Track Capital, LP 4.14% $1.55M 524K Deep Track Capital, LP Dec 31, 2024
Lundbeckfond Invest A/S 1.6% $599K 203K Lundbeckfond Invest A/S Dec 31, 2024

Institutional Holders of OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 10.8M $25.8M -$10.5M $2.39 48
2025 Q1 11.9M $50.1M -$1.57M $4.30 46
2024 Q4 11.8M $99.2M +$89M $8.60 49
2024 Q3 3.2K $5.44K +$5.44K $1.70 1